{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:26:54Z","timestamp":1791991614316,"version":"4.4.0"},"reference-count":82,"publisher":"Wiley","issue":"s5","license":[{"start":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T00:00:00Z","timestamp":1096416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Oesophagitis is associated with Barrett's metaplasia in about 10% of individuals. The UK has one of the highest world\u2010wide prevalences of Barrett's metaplasia, with 1% of adults having the condition, resulting in an incidence of oesophageal adenocarcinoma two to three times that seen in either Europe or North America. In addition, the conversion rate to cancer in individuals with Barrett's metaplasia in UK surveillance programmes is twice that observed in the USA (0.96% per year vs. 0.4% per year), lending further support to the notion that the UK is a high\u2010risk region. The evidence base on what can be achieved with medical therapy to reduce the risk of dysplasia or the development of adenocarcinoma needs to be strengthened with data from randomized controlled trials, as existing data have many limitations. Patients with Barrett's metaplasia respond variably to proton pump inhibitor therapy (even high\u2010dose therapy \u2018normalizes\u2019 acid reflux in only 85% of cases), and symptom control is a poor determinant of the adequacy of suppression of acid reflux. Gastro\u2010oesophageal reflux is implicated in the pathogenesis of Barrett's metaplasia, and <jats:italic>ex vivo and in vitro<\/jats:italic> evidence suggests that its attenuation reverses proliferation and biological variables over days, and perhaps the metaplastic histology to a degree over years. The effect of proton pump inhibitor therapy on cancer risk in the long term is essentially unknown. Acid suppressant therapy or anti\u2010reflux surgery on its own does not result in the complete regression of the metaplastic epithelium. Bile acids, present especially frequently in the refluxate of Barrett's oesophagus patients, are also likely to influence the development and persistence of metaplasia. Barrett's metaplasia is replaced by a squamous epithelium when acid reflux is well controlled and the epithelium is physically destroyed by ablation with argon plasma coagulation or photodynamic therapy. These modalities are invasive and are not likely to be useful in the routine management of patients with Barrett's oesophagus without dysplasia or cancer. Why metaplasia does not fully regress once external initiating stimuli are removed is a mystery. There is some evidence to implicate a variety of molecules, including cyclo\u2010oxygenase\u20102, tumour necrosis factor\u2010\u03b1, \u03b2\u2010catenin nuclear translocation and mitogen\u2010activated protein kinase signalling, because they are expressed preferentially in metaplastic rather than normal or inflamed squamous oesophageal mucosa. The use of non\u2010steroidal anti\u2010inflammatory drugs, including aspirin, is associated with a decreased incidence of oesophageal adenocarcinoma. There is therefore a great need for randomized controlled trials to assess the outcomes of such chemopreventive therapy in patients with Barrett's metaplasia.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02143.x","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T08:49:09Z","timestamp":1096447749000},"page":"71-80","source":"Crossref","is-referenced-by-count":30,"title":["Review article: management of oesophageal adenocarcinoma \u2014 control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus"],"prefix":"10.1111","volume":"20","author":[{"given":"J. A.","family":"Jankowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,29]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03411-5"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2331"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(85)80031-3"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91510-B"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.6.1415"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.5.620"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70318-6"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(91)90367-M"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2002.00217.x"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70136-3"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25065"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)80098-7"},{"key":"e_1_2_12_14_2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5223(94)70178-4","article-title":"Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and non surveyed patients","volume":"108","author":"Peters JH","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.4.574"},{"key":"e_1_2_12_16_2","first-page":"670","article-title":"A guide for surveillance of patients with Barrett's esophagus","volume":"89","author":"Provenzale D","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00332-9"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31599"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.9.1155"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(89)80011-3"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1999.0029900327"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(98)00243-3"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-11-199906010-00003"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00116-1"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9352846"},{"key":"e_1_2_12_27_2","volume-title":"Guidance in Commissioning Cancer Services: Improving Outcomes in Upper Gastrointestinal Cancer \u2014 the Research Evidence","author":"NHS Executive.","year":"2001"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7259.463"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930815)72:4<1155::AID-CNCR2820720404>3.0.CO;2-C"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198310000-00016"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65346-1"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.13.1411"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01758.x"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.6.727"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199705000-00019"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50091"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.2.144"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2003.00328.x"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.01273.x"},{"key":"e_1_2_12_40_2","first-page":"989","article-title":"Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus","volume":"89","author":"Katzka DA","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.211_a.x"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05532.x"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30993"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119018"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70254-X"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2001.00145.x"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.4.489"},{"key":"e_1_2_12_48_2","first-page":"582","article-title":"Normalisation of esophageal pH with high dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus","volume":"92","author":"Sharma P","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.2.257"},{"key":"e_1_2_12_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205731"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.29587"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01430.x"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026615905170"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00749.x"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00543.2001"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2000.278.6.G1000"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.29781"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.174"},{"key":"e_1_2_12_59_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-197-43272"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01240.x"},{"key":"e_1_2_12_61_2","first-page":"124","article-title":"Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor alpha induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK\u2010N\u2010SH cells.","volume":"10","author":"Kim KY","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_12_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200210000-00011"},{"key":"e_1_2_12_63_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.2.407"},{"key":"e_1_2_12_64_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.5.1251"},{"key":"e_1_2_12_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204123"},{"key":"e_1_2_12_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(03)00379-7"},{"key":"e_1_2_12_67_2","first-page":"202","article-title":"Effects of nonsteroidal anti\u2010inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents","volume":"8","author":"Rodriguez\u2010Burford C","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_12_68_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.3.639"},{"key":"e_1_2_12_69_2","first-page":"7060","article-title":"Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min\/+) and Apc(Min\/+), Msh2(\u2010\/\u2010) mice","volume":"61","author":"Sansom OJ","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_12_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03599.x"},{"key":"e_1_2_12_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(97)00144-5"},{"key":"e_1_2_12_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1997.01430310042007"},{"key":"e_1_2_12_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/1475956021000039017"},{"key":"e_1_2_12_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199806000-00003"},{"key":"e_1_2_12_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012015"},{"key":"e_1_2_12_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/35094017"},{"key":"e_1_2_12_77_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31879"},{"key":"e_1_2_12_78_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50008"},{"key":"e_1_2_12_79_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-3-200008010-00007"},{"key":"e_1_2_12_80_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.7.942"},{"key":"e_1_2_12_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70135-1"},{"key":"e_1_2_12_82_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609010347"},{"key":"e_1_2_12_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh171"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02143.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02143.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02143.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:46:39Z","timestamp":1695732399000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02143.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,29]]},"references-count":82,"journal-issue":{"issue":"s5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02143.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02143.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,29]]}}}